Surgery Partners Inc (SGRY)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $3.53B
Last updated: Nov 17, 2026 at 4:10 PM ET
Surgery Partners Inc (SGRY) Stock Chart
Surgery Partners (SGRY) has a latest price of $26.85 on Nov 17, 2026, 1.4% below its 52-week high of $27.23. Its price rose 75.7% over the past 12 months. The month-end price rose 44.2% over the 10 years through Oct 2026, a compound annual rate of 3.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $66.62 in Jun 2021 and its lowest $6.44 in Aug 2019, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SGRY with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SGRY.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 97.4%, and over 6 months it rose 96.1%. The month-end price rose 0.3% over the 3 years through Oct 2026, a compound annual rate of 0.1%.
| Period | Change |
|---|---|
| 1 month | +82.5% |
| 3 months | +97.4% |
| 6 months | +96.1% |
| 12 months | +75.7% |
| 12 months, with dividends | +75.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +0.3% | +0.1% |
| 5 years | -43.6% | -10.8% |
| 10 years | +44.2% | +3.7% |
Price by Year
Its best calendar year was 2020, when the price rose 85.3%, and its weakest was 2022, when it fell 47.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $23.21 | +50.2% |
| 2025 | $15.45 | -27.0% |
| 2024 | $21.17 | -33.8% |
| 2023 | $31.99 | +14.8% |
| 2022 | $27.86 | -47.8% |
| 2021 | $53.41 | +84.1% |
| 2020 | $29.01 | +85.3% |
| 2019 | $15.65 | +59.9% |
| 2018 | $9.79 | -19.1% |
| 2017 | $12.10 | -23.7% |
Trading Range
The price is 50.8% above its 50-day average of $17.81 and 76.5% above its 200-day average of $15.21.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $26.85 | |
| 52-week high | $27.23 | -1.4% |
| 52-week low | $11.41 | +135.3% |
| 50-day average | $17.81 | +50.8% |
| 200-day average | $15.21 | +76.5% |
Price Risk
Over 3 years, its largest fall from a peak was 67.6%.
| Measure | Value |
|---|---|
| 1-year beta | 1.02 |
| Largest fall, 1 year | -34.0% |
| Largest fall, 3 years | -67.6% |
Valuation
Surgery Partners traded at 33.6x earnings at the end of 2025, against a 5-year median of 34.1x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SGRY
What is SGRY's 1-year price change?
Surgery Partners's price rose 75.7% over the past 12 months. With dividends included, the 12-month total return was 75.7%.
What is SGRY's 5-year price change?
Surgery Partners's month-end price fell 43.6% over the 5 years through Oct 2026, a compound annual decline of 10.8%. These figures leave out dividends.
What is SGRY's 52-week high and low?
Surgery Partners's 52-week high is $27.23 and its 52-week low is $11.41. Its latest price of $26.85 on Nov 17, 2026 is 1.4% below the high.
What is SGRY's beta?
Surgery Partners's 1-year beta against the S&P 500 is 1.02, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 34.0%.
Is the SGRY chart free?
Yes. Advanced Charting for SGRY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SGRY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors